Last reviewed · How we verify
using Indocyanine Green
At a glance
| Generic name | using Indocyanine Green |
|---|---|
| Also known as | IV Indocyanine Green injection |
| Sponsor | Ankara University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery (NA)
- Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer (NA)
- Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling
- Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors (PHASE2)
- Prospective Single-Arm Safety Study of Cervical LVA in AD Patients (PHASE1)
- Impact of Intraoperative ICG on Functional Outc in RARP (EARLY_PHASE1)
- Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
- Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- using Indocyanine Green CI brief — competitive landscape report
- using Indocyanine Green updates RSS · CI watch RSS
- Ankara University portfolio CI